Speaker Profile
Chief Commercial Officer, Evidation Health
Biography
Phil Johnson is a recognized leader in advancing healthcare innovation through real-world data and digital health solutions. At Evidation, he leverages a community of over 5 million individuals and innovative direct-to-patient, longitudinal data capture capabilities to advance patient-centric health research and accelerate drug development.With deep expertise in technology and real-world data, Phil has a proven track record of improving research and patient outcomes. His previous work includes building Real-World Data initiatives and promoting Clinical Diversity at Tempus AI, as well as launching a healthcare and life sciences division at Amazon Web Services, where he forged strategic partnerships with leading U.S. healthcare organizations.
Talk
Real-world data collected directly from individuals, through surveys, ePROs, and wearables, combined with conventional sources, demonstrates promising potential for generating predictive insights in areas like influenza detection. This approach opens the door to addressing broader challenges, including obesity and related conditions, by empowering individuals and driving advancements in personalized precision medicine.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
- William Oh, Yale Cancer Center
Patient-centric data, such as Real-World Evidence (RWE) and Real-World Data (RWD), has become critical in reshaping drug development and healthcare decision-making. Over the last few years, regulatory agencies like the FDA and EMA have increasingly embraced RWE/RWD for decision-making processes, influencing everything from new drug indications to post-marketing surveillance. The integration of RWE and RWD is not only supporting clinical trial design and regulatory approvals, but also enabling precision medicine by providing deeper insights into patient subpopulations and their outcomes
Sessions:
- PMWC 2025 Award Ceremony
Pioneer Honoree: Isaac Kohane, Harvard
- Keynote: Can AI succeed where humans have failed to personalize medicine?
- Isaac Kohane, Harvard
- From Data to Decisions: Real-Time Patient Insights for Improved Care (PANEL)
Chair: Michael Pfeffer, Stanford Medicine
- Chris Longhurst, UC San Diego Health
- Tanya Townsend, Stanford Children’s
- Kiran Mysore, Sutter Health
- Cherodeep Goswami, UW Health - AI-Powered RWE: Driving Trustworthy Insights and Innovation through Interoperability (PANEL)
Chair: Charles Jaffe, HL7 International
- Chris Longhurst, UC San Diego Health
- Donald Rucker, 1upHealth
- Stan Huff, Graphite Health
- John Ioannidis, Stanford
- Chris Boone, Oracle
- Accelerating Drug Development with Real World Evidence and AI: Amgen's Journey
- Brian Bradbury, Amgen
- AI-Powered RWE: Accelerating Drug Development and Post-Market Applications (PANEL)
Chair: Erik Reinertsen, Demand Discovery Group
- Michelle Chen, Insilico Medicine
- Jun Jeon, Khosla Ventures
- Dan Riskin, Verantos
- Andrew Trister, Verily - Advancing Patient-Centered Outcomes with AI and Real-World Data Integration
- Phil Johnson, Evidation Health
- Leveraging AI and Real-World Evidence to Transform Patient Care in Oncology
- Amrita Basu, UCSF
- How to Implement AI for Faster Readout of Clinical Trails
Chair:William Oh, Yale
- Jennifer Webster, Pfizer
- Brandon Allgood, Parabilis Medicines
- Julian Hong, UCSF
- Michiel Niesen, nference
